FINWIRES · TerminalLIVE
FINWIRES

Hoya Begins Strategic Review of PENTAX Medical Endoscope Business

By

Hoya (TYO:7741) began a strategic review of its medical endoscope business to optimize the company's portfolio and improve capital efficiency, according to a Friday filing with the Korea Exchange.

The PENTAX Medical business has domestic and overseas operations.

Hoya is reviewing options, including a potential sale of the business to a third party.

Domestic operations of the PENTAX Medical business will be transferred to a wholly owned subsidiary via an absorption-type company split, effective Saturday, Aug. 1.

Related Articles